DRI
50
-3
ROP
53
-9
TJX
62
-2
EXPD
43
-4
ALLE
37
-4
CPB
22
-5
DD
53
-6
SLB
52
-3
KR
36
-6
AVGO
18
-9
DG
8
-2
JBHT
56
-3
PEG
62
4
ICE
59
-3
LUV
45
-2
SWK
50
-5
PDCO
29
2
WMB
68
2
TSCO
44
-4
AAL
57
-2
DRI
50
-3
ROP
53
-9
TJX
62
-2
EXPD
43
-4
ALLE
37
-4
CPB
22
-5
DD
53
-6
SLB
52
-3
KR
36
-6
AVGO
18
-9
DG
8
-2
JBHT
56
-3
PEG
62
4
ICE
59
-3
LUV
45
-2
SWK
50
-5
PDCO
29
2
WMB
68
2
TSCO
44
-4
AAL
57
-2
Financhill
Back

Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
39

LDP
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc.

Last Price:
20.90
Seasonality Move:
2.46%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
39
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. (LDP) is a Sell

Is Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. a Buy, Sell or Hold?

  • The current Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. [LDP] share price is $20.88. The Score for LDP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • LDP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LDP Stock Price Chart

What is Cohen & Steers Ltd Duration Preferred & Income Fund, Inc.'s stock price today?

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

LDP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 41.23 Sell
Chaikin Money Flow: -8565 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.93 - 21.51) Sell
Bollinger Bands (100): (19.91 - 21.31) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

LDP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.22 Sell
20-day SMA: 21.12 Sell
50-day SMA: 21.23 Sell
200-day SMA: 20.13 Buy
8-day EMA: 21.13 Sell
20-day EMA: 21.17 Sell
50-day EMA: 21.06 Sell
200-day EMA: 20.17 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. Earnings Growth & LDP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):